Not logged in Share Save
Share Save
Share Save
Establishing the patient acceptable symptom state for patient-reported pain outcomes 6 months after breast cancer surgery Kang, Matthewa; Rice, Davida, b; Helsby, Nualac; Somogyi, Andrewd; Kluger, Michala, e; Chiang, Daniela, e, f Share Save
Share Save
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial (vol 223, pg 533, 2023) Loo, Colleen; Glozier, Nick; Barton, David; Baune, Bernhard T.; Mills, Natalie T.; Fitzgerald, Paul; Glue, Paul; Sarma, Shanthi; Galvez-Ortiz, Veronica; Hadzi-Pavlovic, Dusan; Alonzo, Angelo; Dong, Vanessa; Martin, Donel; Nikolin, Stevan; Mitchell, Philip B.; Berk, Michael; Carter, Gregory; Hackett, Maree; Leyden, John; Hood, Sean; Somogyi, Andrew A.; Lapidus, Kyle; Stratton, Elizabeth; Gainsford, Kirsten; Garg, Deepak; Thornton, Nicollette L. R.; Fourrier, Celia; Richardson, Karyn; Rozakis, Demi; Scaria, Anish; Mihalopoulos, Cathrine; Chatterton, Mary Lou; McDonald, William M.; Boyce, Philip; Holtzheimer, Paul E.; Kozel, F. Andrew; Riva-Posse, Patricio; Rodgers, Anthony Share Save
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy Robinson, Katherine M.; Eum, Seenae; Desta, Zeruesenay; Tyndale, Rachel F.; Gaedigk, Andrea; Crist, Richard C.; Haidar, Cyrine E.; Myers, Alan L.; Samer, Caroline F.; Somogyi, Andrew A.; Zubiaur, Pablo; Iwuchukwu, Otito F.; Whirl-Carrillo, Michelle; Klein, Teri E.; Caudle, Kelly E.; Donnelly, Roseann S.; Kharasch, Evan D. Share Save
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS) Martin, Donel M.; Harvey, Anna J.; Baune, Bernard; Berk, Michael; Carter, Gregory L.; Dong, Vanessa; Glozier, Nick; Glue, Paul; Hood, Sean; Hadzi-Pavlovic, Dusan; Hackett, Maree; Mills, Natalie; Sarma, Shanthi; Somogyi, Andrew; Rodgers, Anthony; Loo, Colleen K. Share Save
Share Save
Share Save
Share Save
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial Loo, Colleen; Glozier, Nick; Barton, David; Baune, Bernhard T.; Mills, Natalie T.; Fitzgerald, Paul; Glue, Paul; Sarma, Shanthi; Galvez-Ortiz, Veronica; Hadzi-Pavlovic, Dusan; Alonzo, Angelo; Dong, Vanessa; Martin, Donel; Nikolin, Stevan; Mitchell, Philip B.; Berk, Michael; Carter, Gregory; Hackett, Maree; Leyden, John; Hood, Sean; Somogyi, Andrew A.; Lapidus, Kyle; Stratton, Elizabeth; Gainsford, Kirsten; Garg, Deepak; Thornton, Nicollette L. R.; Fourrier, Celia; Richardson, Karyn; Rozakis, Demi; Scaria, Anish; Mihalopoulos, Cathrine; Chatterton, Mary Lou; McDonald, William M.; Boyce, Philip; Holtzheimer, Paul E.; Kozel, F. Andrew; Riva-Posse, Patricio; Rodgers, Anthony Share Save
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype Gammal, Roseann S.; Pirmohamed, Munir; Somogyi, Andrew A.; Morris, Sarah A.; Formea, Christine M.; Elchynski, Amanda L.; Oshikoya, Kazeem A.; McLeod, Howard L.; Haidar, Cyrine E.; Whirl-Carrillo, Michelle; Klein, Teri E.; Caudle, Kelly E.; Relling, Mary, V Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
